Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial-Reference-Cited by-同舟云学术

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

Published:2004-08 Issue:9433 Volume:364 Page:503-512
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Remuzzi Giuseppe,Lesti Mariadomenica,Gotti Eliana,Ganeva Maria,Dimitrov Borislav D,Ene-Iordache Bogdan,Gherardi Giulia,Donati Donato,Salvadori Maurizio,Sandrini Silvio,Valente Umberto,Segoloni Giuseppe,Mourad Georges,Federico Stefano,Rigotti Paolo,Sparacino Vito,Bosmans Jean-Louis,Perico Norberto,Ruggenenti Piero

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation;Fulton;Drugs,1996

2. RS-61443, a new, potent immunosuppressive agent;Platz;Transplantation,1991

3. Controlled trial of RS 61443 in renal transplant patients receiving cyclosporine monotherapy. Transplant;Salaman;Proc,1993

4. Experience with mycophenolate mofetil (RS-61443) in renal transplantation at a single centre;Deierhoi;Ann Surg,1993

5. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients;Sollinger;Transplantation,1995

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniques;PLOS ONE;2024-07-17

2. Analysis of risk factors and prognosis of diarrhea after renal transplantation;Technology and Health Care;2024-07-12

3. A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation;Asian Biomedicine;2024-06-01

4. Molecular modeling studies of fused pyrimidine derivatives at various receptors;Fused Pyrimidine-Based Drug Discovery;2023

5. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08